Tammy Boggiano Ayo

Placeholder Person Graphic
Tammy Boggiano Ayo, MSc, has a bachelor of science in radiochemistry and a master of science in biotechnology from Havana University. From 2010 to 2016, Tammy was Head of the Development Department at the Center of Molecular Immunology Antyter Plant. She is currently Process Development Director at INIM, an R&D facility at the Center of Molecular Immunology. Her international career has included positions in Spain, India, and China. Her expertise is in mammalian cell culture and fermentation, medium development, purification of mAbs, and glycoproteins.

Related Articles

Figure 4: SDS-PAGE under nonreduced conditions of the fi nal purified SP Sepharose Fast Flow.
Technical
Effects of Tank-Agitated Fermentation on Therapeutic mAb Quality

Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1  and chronic conditions such as cancer

  • 1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061